Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-04-19

FDA Approved: CLARINEX-D 12 HOUR — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA has approved a supplemental application for CLARINEX-D 12 HOUR (desloratadine and pseudoephedrine sulfate) submitted by Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLARINEX-D 12 HOUR (DESLORATADINE AND PSEUDOEPHEDRINE SULFATE)

Snippet

SUPPL AP for CLARINEX-D 12 HOUR (DESLORATADINE AND PSEUDOEPHEDRINE SULFATE)